|
Index of reports
> Cases with Weight Decreased (121)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include weight decreased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 121 Next >>
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-24
Patient:
Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-01-01
Rebetol
Dosage: 2x 200 mg in the morning and 200 mg in the evening
Start date: 2012-08-09
Rebetol
Dosage: unk unk, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
Rebetol
Dosage: 600 mg in the morning and 400 mg in the evening
Administration route: Oral
Start date: 2012-01-01
End date: 2012-08-08
Other drugs received by patient: Vasexten; Januvia; Valsartan and Hydrochlorothiazide; Glucophage; Nobiten
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Renal Function Test Abnormal, Alopecia, Haemorrhoids, Anaemia, Urticaria, Vision Blurred, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2010-10-01
PEG-Intron
Dosage: 120 unk, unk
Start date: 2012-06-20
End date: 2012-08-16
Ribasphere
Dosage: unk
Indication: Hepatitis C
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Fatigue, Rash Generalised, Dyspnoea, Dizziness, Abdominal Pain Upper
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-10
Ribasphere
Indication: Hepatitis C
Other drugs received by patient: Omeprazole; Losartan Potassium; Ascorbic Acid
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dyspnoea, Nausea, Diabetes Mellitus, Hypotension, Anaemia, Rash, Headache, Therapeutic Product Ineffective, Dysgeusia, Fatigue, RED Blood Cell Count Decreased, Asthenia, Lethargy, Epistaxis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
PEG-Intron
Dosage: unk unk, unknown
Start date: 2011-08-17
End date: 2012-04-03
PEG-Intron
Dosage: unk unk, unknown
End date: 2009-10-07
PEG-Intron
Dosage: 0.4 ?g, unknown
PEG-Intron
Dosage: 0.3 ?g, unknown
Ribavirin
Dosage: unk unk, unknown
End date: 2009-10-07
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2008-01-04
End date: 2008-10-03
Ribavirin
Dosage: 200 mg, qd
Ribavirin
Dosage: unk unk, qd
Ribavirin
Dosage: unk unk, qd
Start date: 2011-08-17
End date: 2012-04-03
Ribavirin
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2011-09-14
Other drugs received by patient: Epoetin Alfa
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-15
Patient:
Reactions: Weight Decreased, Tongue Discolouration, Glossodynia, Intraocular Pressure Increased, Oropharyngeal Pain, Suicidal Ideation, Dysgeusia, Hepatitis Viral, Tongue Injury, DRY Mouth
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-04-08
End date: 2012-04-06
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-04-08
End date: 2012-04-06
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-01
End date: 2012-01-15
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Haemoglobin Decreased, Dyspnoea, Transfusion, Decreased Appetite, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-22
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-20
Possible PEG-Intron side effects in
Reported by a pharmacist from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Product Quality Issue, Fatigue, Ageusia, Rash, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, unk
Indication: Hepatitis C
Start date: 2011-11-01
Ribasphere
Dosage: unk
Indication: Hepatitis C
Start date: 2011-11-01
End date: 2012-03-01
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Stomatitis, Nausea, Pain in Extremity, Pain, Bone Pain, Oral Discomfort, Dysgeusia, Haemoglobin Decreased, Fatigue, Malaise, DRY Mouth, Decreased Appetite, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: 600 mg, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Victrelis
Dosage: 2400 mg, unknown
Indication: Hepatitis C
Start date: 2012-03-07
Other drugs received by patient: Geodon; Ferrous Sulfate TAB; Ambien; Promethazine; Prozac; Prilosec
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2005-04-01
End date: 2006-03-03
Pegasys
Dosage: unk
Start date: 2012-03-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Rebetol
Dosage: 3 df, qd
Start date: 2012-03-22
Rebetol
Dosage: unk
Start date: 2005-04-01
End date: 2006-03-03
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-19
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Weight Decreased
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Weight Decreased, Vomiting, Nausea, Dehydration, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-07-01
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Urticaria, Anaemia, Alopecia, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2010-10-01
Ribasphere
Dosage: unk
Indication: Hepatitis C
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, White Blood Cell Count Decreased, Injection Site Erythema, Fatigue, Anaemia, Dizziness
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Start date: 2012-05-08
Victrelis
Dosage: 4 unk, tid
Start date: 2012-04-24
Other drugs received by patient: Ribasphere
Possible PEG-Intron side effects in male
Reported by a consumer/non-health professional from Brazil on 2012-08-07
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Weight Decreased, Drug Ineffective, Pain, Pyrexia, Skin Reaction, Abdominal Discomfort, Weight Increased, Vascular Rupture, Hallucination, Cutaneous Lupus Erythematosus, Cough, Nervousness, Anaemia, Rhinitis, Muscular Weakness, Aggression, Dysgeusia, Insomnia, Alopecia, Anal Haemorrhage, Influenza
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-07-16
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Victrelis
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-16
End date: 2012-07-16
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, Fatigue, Vomiting, Pruritus, Nausea, Chills, Urticaria, Asthenia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-07-13
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Other drugs received by patient: Zofran
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-07
Patient:
Reactions: Weight Decreased, Fatigue, Vomiting, Chills, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-07-13
Victrelis
Indication: Hepatitis C
Other drugs received by patient: Zofran
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Skin Injury, Vomiting, Drug Ineffective, Tooth Extraction, Tooth Infection, Headache, Haematemesis, Pain in JAW
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-05
Rebetol
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-05
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-03
End date: 2012-07-06
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-04
Patient:
Reactions: Weight Decreased, Back Pain, Stomatitis, Nausea, Musculoskeletal Pain, Headache, Constipation, Neck Pain, Feeling Abnormal, Asthenia, Decreased Appetite, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-16
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-16
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-11-23
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-08-01
Patient:
Reactions: Oral Mucosal Blistering, Weight Decreased, Nausea, Pain, Psoriasis, Rash, Fatigue, Alopecia, Hyperthyroidism, RED Blood Cell Sedimentation Rate Increased, Infection Susceptibility Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 60 microgram, unk
Indication: Hepatitis
Start date: 2001-02-15
End date: 2001-05-22
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis
Start date: 2001-02-15
End date: 2001-05-22
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-01
Patient:
Reactions: Weight Decreased, Pruritus, Malaise, Nausea, Anaemia, Insomnia, Haemolytic Anaemia, Asthenia, Paraesthesia
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-09-29
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-12-01
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-07-05
End date: 2011-12-01
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-31
Patient:
Reactions: Weight Decreased, Incontinence, Blood Urine Present, Fatigue, Pallor, Micturition Urgency, Decreased Appetite
Drug(s) suspected as cause:
Incivek
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-01
Ribasphere
Other drugs received by patient: Aspirin; Cyanocobalamin; Metformin Hydrochloride; Omega-3 Marine Triglycerides; Vitamin E
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Weight Decreased, Fatigue, Diarrhoea, Nausea, Injection Site Reaction, Anorectal Discomfort, Headache
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Belgium on 2012-07-30
Patient:
Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
PEG-Intron
Dosage: 120 microgram, qw
Start date: 2012-01-01
Rebetol
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-01-01
Rebetol
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-01-01
Other drugs received by patient: Januvia; Vasexten; Nobiten; Valsartan and Hydrochlorothiazide; Glucophage
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-27
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Glossodynia, Tongue Discolouration, Intraocular Pressure Increased, Oropharyngeal Pain, Suicidal Ideation, Dysgeusia, Hepatitis Viral, Tongue Injury, DRY Mouth
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2011-04-08
End date: 2012-04-06
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2011-04-08
End date: 2012-04-06
Victrelis
Dosage: unk
Indication: Hepatitis C
End date: 2012-04-06
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Hypogeusia, Chills, Oropharyngeal Pain, Death, Cheilitis, Feeling of Body Temperature Change, Pharyngitis, White Blood Cell Count Decreased, Dysphagia, Vomiting, Stomatitis, Anaemia, Full Blood Count Decreased, Haemoglobin Decreased, Dysgeusia, Diarrhoea, Dehydration, Asthenia, Aphonia, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-06-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-08
End date: 2012-06-29
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Brazil on 2012-07-26
Patient:
Reactions: White Blood Cell Count Decreased, Weight Decreased, Dysentery, Diarrhoea, Oedema Peripheral, Abdominal Distension, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 unk, unk
Start date: 2012-06-16
PEG-Intron
Dosage: 120 microgram, unk
Indication: Hepatitis C
Start date: 2012-05-26
End date: 2012-06-15
Ribavirin
Dosage: 2 tablets, bid
Administration route: Oral
Start date: 2002-01-01
End date: 2002-01-01
Ribavirin
Dosage: 2 tablets, qam
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Ribavirin
Dosage: 1 tablet, qpm
Administration route: Oral
Start date: 2012-01-01
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-16
Other drugs received by patient: Filgrastim; Epoetin
Page 1 Next >>
|
